Barclays’s SEQUENOM INC NEW SQNM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q1 | – | Sell |
-15,700
| Closed | -$16K | – | 6724 |
|
|
2015
Q4 | $16K | Buy |
15,700
+800
| +5% | +$1.37K | ﹤0.01% | 5275 |
|
|
2015
Q3 | $15K | Sell |
14,900
-6,000
| -29% | -$14.7K | ﹤0.01% | 5606 |
|
|
2015
Q2 | $63K | Buy |
20,900
+8,700
| +71% | +$32.7K | ﹤0.01% | 5009 |
|
|
2015
Q1 | $37K | Sell |
12,200
-112,000
| -90% | -$411K | ﹤0.01% | 5488 |
|
|
2014
Q4 | $373K | Buy |
124,200
+25,100
| +25% | +$81.3K | ﹤0.01% | 4147 |
|
|
2014
Q3 | $198K | Sell |
99,100
-9,100
| -8% | -$33.3K | ﹤0.01% | 4755 |
|
|
2014
Q2 | $325K | Buy |
108,200
+45,400
| +72% | +$133K | ﹤0.01% | 4381 |
|
|
2014
Q1 | $126K | Sell |
62,800
-3,100
| -5% | -$7.39K | ﹤0.01% | 5245 |
|
|
2013
Q4 | $131K | Buy |
65,900
+4,400
| +7% | +$10.4K | ﹤0.01% | 5410 |
|
|
2013
Q3 | $123K | Sell |
61,500
-30,800
| -33% | -$103K | ﹤0.01% | 5461 |
|
|
2013
Q2 | $389K | Buy |
+92,300
| New | +$369K | ﹤0.01% | 4504 |
|
Barclays's SQNM Position: Q3 2016 in Review
Barclays sold out of SEQUENOM INC NEW (SQNM) in Q3 2016, closing a stake of 14,349 shares — an estimated $13K sold.
Barclays first reported a position in SQNM in Q2 2013 and held it in 13 quarters. The position peaked at $352K in Q3 2014. 0 funds tracked by Wall St. Rank hold SQNM as of Q3 2016.
- Barclays reported no remaining SEQUENOM INC NEW position as of Q3 2016 after selling out during the quarter.
- Barclays sold 14,349 SEQUENOM INC NEW shares in Q3 2016, an estimated $13K.
- Barclays first reported a position in SEQUENOM INC NEW in Q2 2013 and held it in 13 quarters.
- Barclays's SEQUENOM INC NEW position peaked at $352K in Q3 2014.
- 0 funds tracked by Wall St. Rank held SEQUENOM INC NEW as of Q3 2016.
Based on Barclays's 13F filing for Q3 2016, filed 14 Nov 2016.